BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8922304)

  • 1. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
    Rosenblatt KA; Thomas DB
    Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):933-5. PubMed ID: 8922304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and risk of epithelial ovarian cancer.
    Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
    Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubal ligation and the risk of ovarian carcinoma.
    Cornelison TL; Natarajan N; Piver MS; Mettlin CJ
    Cancer Detect Prev; 1997; 21(1):1-6. PubMed ID: 9043756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
    Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
    Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of pregnancy and the risk of epithelial ovarian cancer.
    Whiteman DC; Siskind V; Purdie DM; Green AC
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tubal ligation on the incidence of epithelial cancer of the ovary.
    Koch M; Starreveld AA; Hill GB; Jenkins H
    Cancer Detect Prev; 1984; 7(4):241-5. PubMed ID: 6488215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.
    McGuire V; Felberg A; Mills M; Ostrow KL; DiCioccio R; John EM; West DW; Whittemore AS
    Am J Epidemiol; 2004 Oct; 160(7):613-8. PubMed ID: 15383404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthropometry and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Ness RB; Allen GO
    Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.
    Nagle CM; Olsen CM; Webb PM; Jordan SJ; Whiteman DC; Green AC; ;
    Eur J Cancer; 2008 Nov; 44(16):2477-84. PubMed ID: 18707869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer.
    Wittenberg J; Cook LS; Rossing MA; Weiss NS
    Epidemiology; 1999 Nov; 10(6):761-3. PubMed ID: 10535792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.
    Rice MS; Murphy MA; Vitonis AF; Cramer DW; Titus LJ; Tworoger SS; Terry KL
    Int J Cancer; 2013 Nov; 133(10):2415-21. PubMed ID: 23650079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for ovarian cancer: lesbian and heterosexual women.
    Dibble SL; Roberts SA; Robertson PA; Paul SM
    Oncol Nurs Forum; 2002; 29(1):E1-7. PubMed ID: 11845216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk.
    Mills PK; Riordan DG; Cress RD; Goldsmith DF
    Cancer Detect Prev; 2005; 29(2):124-32. PubMed ID: 15829372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender of offspring and maternal ovarian cancer risk.
    Gierach GL; Modugno F; Ness RB
    Gynecol Oncol; 2006 Jun; 101(3):476-80. PubMed ID: 16364411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial ovarian cancer and combined oral contraceptives. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Int J Epidemiol; 1989 Sep; 18(3):538-45. PubMed ID: 2807655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk.
    Parazzini F; Negri E; La Vecchia C; Luchini L; Mezzopane R
    Obstet Gynecol; 1993 Mar; 81(3):363-6. PubMed ID: 8437787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer.
    Chiaffarino F; Parazzini F; Decarli A; Franceschi S; Talamini R; Montella M; La Vecchia C
    Gynecol Oncol; 2005 May; 97(2):318-22. PubMed ID: 15863124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.